Sanofi profit soars on lower Lemtrada charge
Sanofi SA says its net profit soared 26.3 percent in the fourth quarter thanks to lower charges against Lemtrada, its multiple sclerosis treatment.
Feb 5, 2015
0
4
Sanofi SA says its net profit soared 26.3 percent in the fourth quarter thanks to lower charges against Lemtrada, its multiple sclerosis treatment.
Feb 5, 2015
0
4
British pharmaceuticals group AstraZeneca announced on Thursday a slump in quarterly profits, in part on higher investment costs, but raised its outlook for full-year revenues.
Nov 6, 2014
0
0
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
Swiss pharmaceuticals giant Roche on Thursday posted an 18-percent hike in net profit for 2013, driven particularly by rising sales of its cancer-fighting drugs.
Jan 30, 2014
0
0
Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
Jan 29, 2014
0
0
German chemicals and pharmaceuticals giant Merck KGaA said Thursday it is raising its full-year operating profit forecast thanks to improving sales and positive cost-cutting effects.
Nov 14, 2013
0
0
India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.
Oct 31, 2013
0
0
French pharmaceutical group Sanofi reported a slump in profits for the third quarter of the year on Wednesday owing to the lagging effects of the ending of exclusive patent rights.
Oct 30, 2013
0
0
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
Biotech drugmaker Amgen Inc. said Tuesday that its third-quarter profit jumped 24 percent, trouncing analysts' expectations, as sales of more than a half-dozen of its drugs increased by double digits.
Oct 22, 2013
0
0